Advocates urged House representatives to back a FY2026 budget that preserves the Senate Appropriations Committee’s NIH funding level of $48.7 billion and maintains Senate language protecting indirect-cost caps and multi‑year grant limits consistent with FY2024. The call emphasizes rapid action to prevent policy shifts that could constrain research funding stability and university overhead recovery. Stakeholders warned that changes to multi‑year grant rules and caps on indirect costs would materially affect institutional budgeting for large translational programs and long‑lead projects, urging lawmakers to retain provisions that support sustained biomedical research infrastructure.